Bradley Canino

Stock Analyst at Stifel

(0)
# 4809
Out of 5,338 analysts
102
Total ratings
21.43%
Success rate
-22.86%
Average return
Main Sectors:
Top Industries:
22 Stocks
Name Action PT Current % Upside Ratings Updated
BDTX Black Diamond Therap...
Maintains: Buy
16 15
1.93 677.2% 5 Mar 7, 2025
ALXO ALX Oncology Holding...
Maintains: Hold
3 2
0.44 240.91% 8 Mar 7, 2025
RLAY Relay Therapeutics
Maintains: Buy
27 23
2.8 721.43% 5 Feb 27, 2025
ARVN Arvinas
Maintains: Buy
63 51
6.25 716% 6 Feb 12, 2025
JANX Janux Therapeutics
Maintains: Strong Buy
70 115
23.33 392.93% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 4
0.08 4900% 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
40 41
8.93 359.13% 5 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
26 19
5.93 220.4% 6 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
39 42
10.54 298.48% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
23.05 73.54% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
71.03 90.06% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
4.72 323.73% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.09 817.43% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
1.25 700% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
40.01 147.44% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
1.39 907.19% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
7.23 453.25% 1 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
99.45 30.72% 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
29.96 83.58% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
n/a n/a 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022